DXCM vs MDT
Dexcom (DXCM) and Medtronic (MDT) compared side by side. Medtronic (MDT) is larger, with a market cap of $122.0B versus $29.4B for Dexcom, about 4.1 times the size. On trailing earnings, MDT is cheaper at 23.4x versus 30.9x for DXCM.
Head to head
| Metric | DXCM | MDT |
|---|---|---|
| Market cap | $29.4B | $122.0B |
| P/E (TTM) | 30.9x | 23.4x |
| Forward P/E | 25.0x | 14.9x |
| Revenue (TTM) | $5.0B | $37.5B |
| Revenue growth | 13.1% | 13.7% |
| Gross margin | 62.5% | 65.3% |
| Operating margin | 24.3% | 19.3% |
| Free cash flow | $1.4B | $6.1B |
| Dividend yield | None | 3.02% |
| 1-year return | +9.7% | +4.6% |
| 5-year return (annual) | -11.3% | -1.9% |
| Max drawdown | -95% | -73% |
| FI Handbook grade | B+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$5.0K
$7.5K
$10.0K
20222023202420252026
DXCM vs MDT FAQ
Which is bigger, DXCM or MDT?
Medtronic (MDT) is larger, with a market cap of $122.0B versus $29.4B for Dexcom, about 4.1 times the size.
Is DXCM or MDT cheaper?
On trailing earnings, MDT is cheaper at 23.4x versus 30.9x for DXCM. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, DXCM or MDT?
DXCM returned +9.7% over the past year including dividends, versus +4.6% for MDT, through October 23, 2026.
Which pays a higher dividend, DXCM or MDT?
MDT yields 3.02%; DXCM does not pay a dividend.